Benefit of Vasodilating β-Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study.
作者:
主题词
肾上腺素能β受体拮抗剂(Adrenergic beta-Antagonists);老年人(Aged);卡方分布(Chi-Square Distribution);女(雌)性(Female);心力衰竭(Heart Failure);住院(Hospitalization);人类(Humans);发病率(Incidence);Kaplan-Meiers评估(Kaplan-Meier Estimate);Logistic模型(Logistic Models);男(雄)性(Male);中年人(Middle Aged);多元分析(Multivariate Analysis);心肌梗死(Myocardial Infarction);倾向性评分(Propensity Score);比例危险度模型(Proportional Hazards Models);复发(Recurrence);登记(Registries);韩国(Republic of Korea);危险因素(Risk Factors);支架(Stents);时间因素(Time Factors);治疗结果(Treatment Outcome);血管舒张药(Vasodilator Agents)
DOI
10.1161/JAHA.117.007063
PMID
29066446
发布时间
2024-07-15
- 浏览13
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文